# Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects

> **NCT02201368** · PHASE3 · WITHDRAWN · sponsor: **Maria Luz Couce Pico**

## Conditions studied

- Long-chain Fatty Acid Transport Deficiency

## Interventions

- **DRUG:** Triheptanoin (SpezialölÒ 107®)
- **DIETARY_SUPPLEMENT:** MCT (Medium-Chain Triglycerides)

## Key facts

- **NCT ID:** NCT02201368
- **Lead sponsor:** Maria Luz Couce Pico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2011-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IMP management difficulties
- **Last updated:** 2014-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201368, "Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02201368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*